bcbs glp-1 Why Blue Cross Blue Shield is rolling back coverage of weight loss drugs in Massachusetts BCBSM pulling back on GLP-1

Central infusions of leptin and GLP-1-(7-36) amide differentially stimulate c-FLI in the rat brain

In the ITT approach, patients were followed from the index date to the event, death, or the last available observation, whichever occurred first

Hammoud R, Drucker DJ (2022) Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1

When you combine reduced fluid intake with the fact that these medications can alter how your kidneys process salt, you have a recipe for imbalance

As healthcare providers and fitness specialists, it is essential that we educate our patients/clients and foster healthy habits, especially for diseases linked to lifestyle

Originally developed for type 2 diabetes, semaglutide has shown exceptional promise in promoting sustainable weight loss